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Scope: Antibiotic stewardship programmes (ASPs) are necessary in hospitals to improve the judicious
use of antibiotics. While ASPs require complex change of key behaviours on individual, team organization
and policy levels, evidence from the behavioural sciences is underutilized in antibiotic stewardship
studies across the world, including high-income countries (HICs). A consensus procedure was performed
to propose research priority areas for optimizing effective implementation of ASPs in hospital settings
using a behavioural perspective.
Methods: A workgroup for behavioural approaches to ASPs was convened in response to the fourth call
for leading expert network proposals by the Joint Programming Initiative on Antimicrobial Resistance
(JPIAMR). Eighteen clinical and academic specialists in antibiotic stewardship, implementation science
and behaviour change from four HICs with publicly funded healthcare systems (e.g. Canada, Germany,
Norway and the UK) met face-to-face to agree on broad research priority areas using a structured
consensus method.
Question addressed and recommendations: The consensus process assessing the ten identiﬁed research
priority areas resulted in recommendations that need urgent scientiﬁc interest and funding to optimize
effective implementation of ASPs for hospital inpatients in HICs with publicly funded healthcare systems.
We suggest and detail behavioural science evidenceeguided research efforts in the following areas: (a)
comprehensively identifying barriers and facilitators to implementing ASPs and clinical recommenda-
tions intended to optimize antibiotic prescribing; (b) identifying actors (‘who’) and actions (‘what needs
to be done’) of ASPs and clinical teams; (c) synthesizing available evidence to support future research and
planning for ASPs; (d) specifying the activities in current ASPs with the purpose of deﬁning a controlrvices Research Unit, Health
K.
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M. Rzewuska et al. / Clinical Microbiology and Infection 25 (2019) 163e168164group for comparison with new initiatives; (e) deﬁning a balanced set of outcomes and measures to
evaluate the effects of interventions focused on reducing unnecessary exposure to antibiotics; (f) con-
ducting robust evaluations of ASPs with built-in process evaluations and ﬁdelity assessments; (g)
deﬁning and designing ASPs; (h) establishing the evidence base for impact of ASPs on resistance; (i)
investigating the role and impact of government and policy contexts on ASPs; and (j) understanding
what matters to patients in ASPs in hospitals.
Conclusions: Assessment, revisions and updates of our priority-setting exercise should be considered at
intervals of 2 years. To propose research priority areas in low- and middle-income countries, the
methodology reported here could be applied. M. Rzewuska, Clin Microbiol Infect 2019;25:163
© 2018 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Scope
The proposed overarching priority research areas are intended
for researchers, representatives from funding agencies and policy
makers. These priorities provide suggestions on what needs urgent
scientiﬁc interest and funding to optimize effective implementa-
tion of antibiotic stewardship programmes (ASPs) for hospital in-
patients using theoretical and empirical evidence from behavioural
sciences. We based these suggestions on experiences from HICs
with publicly funded healthcare systems, where most evidence on
antibiotic stewardship come from.Context
Antibiotic resistance is a globally important problem associated
with excess mortality and morbidity, prolonged hospital stays and
increased healthcare costs [1]. Overuse or inappropriate use of
antibiotics drives the development of antibiotic resistance [2]. Most
human consumption of antibiotics occurs in primary-care settings
and nursing homes [3], but antibiotic resistance has predominantly
been a clinical problem in hospitals, which are particularly sus-
ceptible to harbouring multidrug-resistant organisms [4]. There-
fore, antibiotic stewardship is essential to improve the judicious use
of antibiotics in hospitals by providing practitioners with tools to
prescribe effective therapy while reducing antibiotic-related
adverse events, such as antibiotic resistance [1,4].
An antibiotic stewardship programme (ASP) is a coherent set of
collective daily actions that promotes using antibiotic agents
responsibly, where ‘action’ is deﬁned as a strategy (i.e. a speciﬁc set
of coherent interventions) [5]. In practice, ASPs involve a hetero-
geneous group of system- and organization-based actions, so un-
derstandably there is not only substantial transnational variability
in the development and implementation of ASPs [6] but even
organization-level variability in HICs [7e10]. This suggests a global
need to optimize and standardize the implementation of ASPs.
Coordinated transnational response efforts are underway to
enhance the implementation (i.e. uptake into practice and policy)
of effective ASPs [4]. The planning of such large-scale quality
improvement initiatives ﬁrst requires optimizing the use of existing
research resource management [11]. The growing number of
research projects on ASPs being conducted and submitted for
publication demonstrates that it is a priority area [12], but a
number of important research gaps still need to be addressed [4].
Addressing high-importance questions (i.e. research priorities) will
reduce avoidable research waste [11]. Core elements and checklist
items for global ASPs, including in low- and middle-income coun-
tries (LMICs), where most of antibiotics are prescribed, have been
developed [13], but without a behavioural lens. More robustqualitative research investigating contextual inﬂuences on ASPs is
needed from LMICs to propose research priorities for those coun-
tries using a behavioural lens.
An ASP requires complex behaviour change; multiple healthcare
providers are required to change multiple behaviours at different
time points in the patient care pathway. Moreover, change is
required at the individual, team organization and policy levels to
change key behaviours. It has beenwidely recognized that evidence
from behavioural science can be used to inform that change
[3,4,14,15]. The underlying principle of this need is understanding
the difference between recommendations for appropriate anti-
biotic use (the ‘what’) and behaviour change interventions (the
‘how’) [3]. To inform the development of a more effective health
behaviour change intervention (i.e. a systematic interference
designed to modify how an individual acts), researchers have
started to specify the active ingredients of interventions in terms of
their component behaviour change techniques (BCTs) [16]. BCTs are
the observable, replicable components of behaviour change in-
terventions.We know from a Cochrane review that interventions to
improve the translation of antibiotic use recommendations into
practice are effective in increasing compliance with antibiotic
policy and reducing duration of antibiotic treatment in acute care
hospital settings [14]. However, the review suggests that few of
those interventions used effective BCTs (e.g. action planning or
feedback), the role of a key stakeholder (i.e. junior doctors) is
mostly overlooked, and interventions are developed at the local
level on an ad hoc basis [14]. One of the main recommendations
from the review included a need to bring together world experts in
antibiotic stewardship in partnership with experts in imple-
mentation and social sciences to develop a research agenda to
guide future research efforts to optimize effective implementation
of ASPs in hospital settings [14].
Question addressed
What are the research priority areas to optimize effective
implementation of ASPs in hospital settings in HICs with publicly
funded healthcare systems?
Methods
Description of development group
A transnational multidisciplinary workgroup on behavioural
approaches to ASPs was convened in response to the fourth call for
leading experts' network proposals of the Joint Programming
Initiative on Antimicrobial Resistance (JPIAMR). The steering
committee (CR, JMG, PGD) identiﬁed 16 members (all the other
coauthors) through a process of peer knowledge sharing and
consultation through existing research networks and contacts.
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antibiotic stewardship, behavioural and implementation science,
including clinical leads, senior academic staff or experts for health
authorities or policy makers, with at least 10 years of experience in
their subject area; or being frontline clinical staff, clinical-academic
or nonclinical academic staff with extensive experience in the
above three areas; and coming from a HICs with publicly funded
healthcare systems. In total, the group included 19 members from
the United Kingdom (n ¼ 11), Germany (n ¼ 2), Norway (n ¼ 2) and
Canada (n ¼ 4). The members had different backgrounds, including
infectious disease physicians, nurses and researchers; imple-
mentation scientists; health psychologists; intervention design
methodologists; and healthcare service scientists (Supplementary
Materials S1).
Consensus procedure
The workgroup met face-to-face on 27e28 April 2017 in Bir-
mingham, UK, and 30e31 October 2017 in Aberdeen, UK. Meetings
were audiorecorded and summarized, and notes were taken. To
ensure that the priority-setting team had necessary information
about the context [17], each meeting was guided by an agenda for
activities, including practical group work and presentations of
knowledge synthesis undertaken by the workgroup. The latter
included a nonsystematic review and knowledge synthesis of
existing evidence on ASP implementation efforts worldwide; a
systematic review of multicountry studies on barriers and facilita-
tors to ASPs in hospitals (PROSPERO registration CRD42017076425);
and the Cochrane review of interventions to improve antibiotic
prescribing to hospital inpatients [14].
The stages of the priority setting process were informed by
existing literature [18] and are summarized in Fig. 1. We used the
nominal group technique, a commonly used formal consensus
development method involving a highly structured face-to-face
group interaction. Practical beneﬁts for which we chose the nomi-
nal grouptechnique included: immediatedisseminationof results to
the group [19], giving equal voice to each participant byencouraging
individual input [19], reduction of personality effects (e.g. inﬂuences
of a power structure) and creating an environment conducive to
initiation of change [20]. In our experience, research needs within
the area of behavioural approaches toASPs are vast and intertwined.
Also, in practice, speciﬁc research questions are likely to vary across
systems and speciﬁc settings [8]. Therefore, similar to Healy et al.
[21], we used a modiﬁed James Lind Alliance (JLA) process [22],
which led to suggestinguniquebroadgeneral prioritization research
areas rather than speciﬁc research questions.Fig. 1. Stages of research priorities setting process for antThe process protocol is presented in Supplementary Materials
S1. The session began with the workgroup coordinator (CR)
providing an introduction to the whole group and explaining the
purpose of the activity. Participating members then split into two
equal-size groups. Each group was allocated one consensus
decision-making process facilitator (KG and EMD). Both have been
previously involve in a consensus process, and one facilitator (KG)
also had previous experience with the JLA process. We selected
facilitators with the skills to unite differing perspectives and
spheres of expertise and to enable interaction [23]. To capture
experiential differences in people with similar background, thereby
giving rise to new perspectives, participants with similar areas of
expertisewere grouped together (e.g. experts in infectious diseases,
and health psychology and implementation). At the same time, to
stimulate discussion, each group included subgroups with at least
three different areas of expertise, and we also included a clinical-
academic in each group. Participants were asked to generate spe-
ciﬁc research ideas in these groups. For this purpose, in silence,
participants wrote down research ideas on provided sticky notes.
They were instructed to write one idea per note and were
encouraged to use as many notes as needed. Each participant pre-
sented and brought their research ideas forward for discussion in
their groups by reading them aloud and explaining their choices. All
ideas were collected, numbered and displayed on a ﬂipchart board
by a group facilitator. All participants were then asked to read the
ideas generated by the other group.
Participants were brought together through discussion and
inductively collated overlapping research ideas into topics. In the
JLA process of priority settingda well-established frame-
workdtypically the main focus is to agree the list of the top ten
priorities for future research [22]. However, to avoid artiﬁcial
consensus, the group was not informed about this speciﬁc number.
Instead, we planned to offer the group an option to decide how
many research priority topics would be carried forward for ranking,
and we prepared a priori a strategy to reduce the number of
generated topics if necessary (Supplementary Materials S1).
After a short break, each participant was providedwith a printed
copy of the prioritized research topics and asked to rank these pri-
orities from most to least important. An e-polling system that col-
lects and summarizes responses was used to collate the ranking of
the priority ideas. Responses were submitted using personal elec-
tronic devices. After an interval for another activity, the results were
presented to the group on a large projection screen. A facilitator
then guided the participants through listening to each idea, opinion
and concern, and initiated discussion to reach consensus (i.e. a so-
lution that everyone actively supports or at least can accept).ibiotic stewardship programmes in hospital settings.
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Consensus process
The consensus process for research priority setting took place in
Aberdeen in October 2017 and lasted 2.5 hours. Sixteen members
generated and collated research ideas into topics, of whom 15 (one
person had to leave an activity early) ranked the prioritized
research topics. After discussion, the group spontaneously collated
individually generated overlapping research ideas into ten research
topics, so there was no need to consider reducing the numbers of
generated topics. During the discussion of the results of ranking of
the prioritized research topics, the group concluded that the top
ﬁve research priorities received similar ranking scores; priority
research areas are interdependent, and so research is much needed
across all ten areas.
The dynamic of each group was different because of different
personalities, experiences, expertise, backgrounds, communication
styles and levels of conﬁdence. The discussions were vigorous,
however, and each participant took strong ownership of his or her
own proposed ideas. The presence of a facilitator, with experience
in both behavioural and implementation science, to moderate
those discussions ensured mutual understanding. Placing in-
dividuals with similar background and prior presentations and
group activities also facilitated shared understanding. In the next
step, pragmatism was required to collate individual research ideas
to reach acceptable compromises and revision of opinions in the
search for consensus. At this point the group required the assis-
tance of the second facilitator and an administrator for record
keeping, to ensure full, fair, respectful and equal participation.
Recommendations
Table 1 lists the priorities and ranked research topics grouped
into three main descriptive themes. Individual research ideas are
presented in Supplementary Materials S2. We would anticipate
research teams to select the broad research areas prioritized and
develop a speciﬁc research project from them. For example, one
research objective for the top research priority would be devel-
oping a core outcome set which reﬂected clinicians' and patients'
views to enable evaluation of effectiveness of an intervention to
support behaviour change, which was speciﬁed in terms of target,
action, context, time, actor (TACTA), focusing on reducingTable 1
Prioritized ten research topicsdan overarching aspiration: more impactful hospital ASPs
Theme Research priority area
Theme 1. Establishing the evidence base and
understanding current practice in ASPs
Comprehensively identifying barrie
clinical recommendations intended
(i.e. good clinical practice for antibi
Identifying actors (‘who’) and action
Synthesizing available evidence to s
Specifying the activities in current A
for comparison with new initiatives
Theme 2. Design and evaluation of ASPs Deﬁning a balanced set of outcome
interventions focused on reducing u
Conducting robust evaluations of A
Deﬁning and designing ASPs.
Theme III. Research priority topics crosscutting
to themes 1 and 2
Establishing the evidence base for i
Investigating the role and impact o
Understanding what matters to pat
ASP, antibiotic stewardship programme.
a The involvement of patients in hospital antibiotic stewardship research has been tradi
antimicrobials in hospital settings are typically more ill than patients treated in primary c
care.unnecessary exposure to antibiotics in hospital patients. Within the
second top research priority topic, a speciﬁc research objective
could be developing and piloting a multicentre, transnational,
cluster-randomized controlled trial to compare short- and long-
term effects of two ASPs with different BCT-speciﬁed antibiotic
stewardship interventions in hospital inpatient settings. An
example research objective within the third research topic might
be: Estimating short- and long-term effects of TACTA-speciﬁed ASP
behaviours on Gram-negative and Gram-positive bacteria using a
controlled interventional study design and data reporting.
Implications
The main implication of this consensus work is potentially
reducing avoidable waste and inefﬁciency in research by directing
future research to address the proposed uncertainties of impor-
tance [23]. To facilitate this process, participation of a priority-
setting team in discussion with the community of interest, to
share ﬁndings and experiences, is recommended [17]. Research
teams are encouraged to identify opportunities for building robust
proposals focused on comprehensively addressing research objec-
tives within these priorities. Robust proposals could be informed by
recommendations for avoiding research waste [11] as well as by
guidance on designing and reporting of ASP intervention studies
[24,25], implementation studies [26] and behaviour change in-
terventions [27,28]. ASPs are a global concern and are thus best
addressed by engaging existing research teams to collaborate
internationally and contribute evidence to answer the prioritized
research topics.
The JPIAMR Virtual Research Institute has offered to provide a
platform to achieve this by increasing coordination, improving
visibility and facilitating knowledge exchange globally (https://
www.jpiamr.eu/activities/jpiamr-virtual-research-institute/). A
promising innovative solution for contributing generalizable evi-
dence is implementation laboratories [29], such as the one pro-
posed for audit and feedback (http://www.ohri.ca/auditfeedback/).
For ASPs, this would involve a research team integrated into
healthcare systems undertaking research projects directly relevant
to the healthcare systems' priorities for ASPs. This could offer a
much-needed platform for moving forward from small-scale
studies developed on an ad hoc basis towards coordinated large-
scale initiatives focusing on applied research to develop, imple-
ment and evaluate theoretically informed ASPs in differentOverall ranking
rs and facilitators to implementing ASPs and
to optimize antibiotic prescribing
otic use).
4
s (‘what needs to be done’) of ASPs and clinical teams. 6
upport future research and planning for ASPs. 7
SPs with the purpose of deﬁning a ‘control group’
.
8
s and measures to evaluate the effects of
nnecessary exposure to antibiotics.
1
SPs with built-in process evaluations and ﬁdelity assessments. 2
5
mpact of ASPs on resistance. 3
f government and policy contexts on ASPs. 9
ients in ASPs in hospitals.a 10
tionally limited and hencewas ranked as No. 10. This is because patients treatedwith
are settings, so they may have less capacity to make their own decisions about their
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research efforts are needed to take this agenda forwards. According
to Chalmers et al. [23], ‘Research funders have primary re-
sponsibility for reduction in waste resulting from decisions about
what research to do,’ and hence they should be encouraged to
integrate set research priorities into their organizational plans,
research strategies and funding calls.
Our aim was to further optimize ASPs for hospital inpatients,
based on experiences of research partners from HICs. Globally, the
majority of prescribing takes place in LMICs [3]. We fully agree with
proposals to advance antibiotic stewardship research in those
countries [4,24], as evidenced by the fact that most of our group
members collaborate with research partners in LMICs. However,
the health research capacity strengthening research ﬁeld with a
focus on implementation science is emerging, and currently evi-
dence bases are not yet sufﬁciently advanced to effectively inform
health research capacity strengthening research programme plan-
ning [30]. On the basis of our best knowledge and experiences, we
recognized that implementation of ASPs varies greatly across types
of healthcare systems, let alone LMICs, so inviting a limited number
partners from LMICs was likely to unfairly prioritize speciﬁc
research needs in their countries. We expect a similar consensus
procedure to be conducted with a range of frontline clinicians and
academics from LMICs with extensive experience with antibiotic
prescribing in partnership with experts in implementation, inter-
vention design and behavioural sciences from HICs and LMICs.
More robust qualitative research investigating contextual in-
ﬂuences on ASPs is needed from LMICs to inform such a consensus
procedure.
We did not include patients whose role in hospital antibiotic
stewardship was traditionally limited but is now starting to in-
crease [31]. We anticipated that a major practical challenge to
include patients would be a need to overcome patient-reported
doubts on their ability to understand antibiotic useerelated med-
ical information [31]. We expect that including patients would
affect the completeness of the prioritized areas; hence, this is
needed. As recommended by Nasser et al. [17], improving and
reﬁning the proposed research priorities should be continued, so
we encourage assessment, revisions and updates of our consensus
process at intervals of 2 years, including involvement of other
stakeholders (e.g. patients). Single systematic literature reviews
around each priority topic could be conducted, where numbers and
types of scientiﬁc publications could serve as a proxy to quantita-
tively assess the impact of our research priority areas.
Conclusions
We propose ten research priorities areasdshared by clinicians
as well as clinical and nonclinical academics from HICs with pub-
licly funded healthcare systemsdfor future research on hospital
ASPs. For this we focused on a behavioural science perspective, a
mode currently underutilized in antibiotic stewardship studies
[3,14,15,32]. This way, we addressed a recognized important gap in
knowledge [14]. We speciﬁed how optimizing implementation of
ASPs will depend on using theoretical and empirical evidence from
behavioural science for knowledge synthesis; investigating imple-
mentation failures; and informing the research community of the
improved design and evaluation of effectiveness, sustainability and
scalability of ASPs as quality improvement initiatives.
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